Old Web
English
Sign In
Acemap
>
authorDetail
>
U. Wählby-Hamrén
U. Wählby-Hamrén
AstraZeneca
Asthma
Medicine
Management science
Cardiotoxicities
Econometrics
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results and learnings from amber, a decentralized phase i study assessing the pharmacokinetic and pharmacodynamic profile of inhaled velsecorat, a non-steroidal, selective glucocorticoid receptor modulator, in adolescents with asthma
2021
American Journal of Respiratory and Critical Care Medicine
Ioannis Psallidas
Sofia Necander
L. M. Thurman
J. E. Ervin
I. Acosta
E. Björnsson
Susanne Prothon
U. Wählby-Hamrén
Alexandra Jauhiainen
Mary N. Brown
B. Valastro
K. Enarsson Rinqvist
Henrik Forsman
Y. Kurdyukova
Cecilia Arfvidsson
L. Sher
Show All
Source
Cite
Save
Citations (0)
Design of a Phase 2b Dose Finding Study of AZD7594, an Inhaled Non-Steroidal, Selective Glucocorticoid Receptor Modulator, for the Treatment of Asthma
2019
G.L. Chupp
Mary Brown
K.M. Beeh
U. Wählby-Hamrén
A.-K. Ekelund
E. Barkstedt
H. Forsman
E. Björnsson
A. Jauhiainen
J. Steele
I. Psallidas
Show All
Source
Cite
Save
Citations (0)
A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation
2018
Journal of Pharmacokinetics and Pharmacodynamics
S. Y. A. Cheung
Joanna Parkinson
U. Wählby-Hamrén
C. D. Dota
Å. M. Kragh
Linnéa Bergenholm
T Vik
Teresa Collins
Cecilia Arfvidsson
Chris Pollard
H. K. Tomkinson
Bengt Hamrén
Show All
Source
Cite
Save
Citations (4)
1